Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)
EMPD is a serious, rare, and life-threatening genital and perianal skin cancer
EMPD is a serious, rare, and life-threatening genital and perianal skin cancer